Summary
This 2022 guideline from the American Heart Association, American College of Cardiology, and Heart Failure Society of America synthesises evidence on heart failure management. As suggested by the title and journal scope, it likely encompasses recommendations on pharmacological therapies, device-based interventions, and supportive care strategies including nutritional management. The guideline appears intended to inform clinical practice and policy around heart failure prevention and treatment.
UK applicability
UK clinicians and health systems may reference this guideline, though National Institute for Health and Care Excellence (NICE) guidance and UK-specific evidence reviews remain primary. Dietary and lifestyle recommendations may have relevance to UK populations, though adaptation to NHS contexts and UK-specific prevalence data would be warranted.
Key measures
Clinical outcomes in heart failure management; recommendations based on level of evidence and class of recommendation
Outcomes reported
The guideline provides evidence-based recommendations for the diagnosis, risk stratification, and management of heart failure across multiple clinical scenarios. It addresses pharmacological and non-pharmacological interventions, including lifestyle modifications and dietary considerations.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.